EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

  • ID: 4370716
  • Drug Pipelines
  • 40 pages
  • GlobalData
1 of 3
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

Summary

Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency (WHO, 2016a). T2D constitutes approximately 90-95% of all diabetes cases around the world while, type 1 diabetes (T1D) and gestational diabetes make up the remaining 5-10% of the cases (CDC, 2011; CDC, 2014b; IDF, 2014).

The prevalence of diabetes is expected to grow rapidly as it is associated with aging populations, increasing urbanization, economic development, and the increase in the prevalence of risk factors like obesity, unhealthy dietary habits, and physical inactivity (IDF, 2015). Globally, diabetes will likely be the seventh-leading cause of death in the world by 2030 (Mathers and Loncar, 2006). Additionally, poorly managed diabetes leads to serious complications such as heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage. Diabetes also increases the risk of fetal death and other complications during pregnancy (WHO, 2016b).

In the 7MM, our epidemiologists forecast an increase in the diagnosed prevalent cases of T2D from 56,060,328 diagnosed prevalent cases in 2016 to 77,823,223 diagnosed prevalent cases in 2026, with an annual growth rate (AGR) of 3.88% during the forecast period. The US will have the highest number of diagnosed prevalent cases of T2D among the 7MM throughout the forecast period, while Italy will have the lowest.

The report "EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026" provides an overview of the risk factors, comorbidities, and the global and historical trends for T2D in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) and also includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age (for ages 20 years and older) and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.

Scope
  • The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of T2D in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age (for ages 20 years and older) and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.
  • The T2D epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to Buy

The T2D EpiCast report will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global T2D market.
  • Quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for T2D therapeutics in each of the markets covered.
  • Identify the percentage of T2D diagnosed prevalent cases by age, sex, and major comorbid disorders.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1.1 List of Tables
1.2 List of Figures

2. Executive Summary
2.1 Related Reports
2.2 Upcoming Reports

3. Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Diagnosed Prevalent Cases of T2D
3.5 Epidemiological Forecast for T2D (2016-2026)
3.5.1 Diagnosed Prevalent Cases of T2D
3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D
3.5.4 Comorbidities Among the Diagnosed Prevalent Cases of T2D
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis

4. Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About
4.4 Contact Us
4.5 Disclaimer

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for T2D.
Table 2: 7MM, Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, Selected Years 2016-2026

1.2 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of T2D, Both Sexes, Ages =20 Years, 2016 and 2026
Figure 2: 7MM, Age-Standardized Diagnosed Prevalence (%) of T2D, Men, Ages =20 Years, 2006-2026
Figure 3: 7MM, Age-Standardized Diagnosed Prevalence (%) of T2D, Women, Ages =20 Years, 2006-2026
Figure 4: 7MM, Sources Used and Not Used, Diagnosed Prevalent Cases of T2D
Figure 5: 7MM, Sources Used, Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D
Figure 6: 7MM, Sources Used, Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D
Figure 7: 7MM, Sources Used, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
Figure 8: 7MM, Sources Used, Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D
Figure 9: 7MM, Sources Used, Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D
Figure 10: 7MM, Age-Specific Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Figure 11 : 7MM, Sex-Specific Diagnosed Prevalent Cases of T2D, Ages =20 Years, N, 2016
Figure 12: 7MM, Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Figure 13: 7MM, Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Figure 14: 7MM, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Figure 15: 7MM, Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Figure 16: 7MM, Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D, Ages =20 Years, Both Sexes, N, 2016
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll